|
BE615511A
(enExample)
|
1961-03-25 |
|
|
|
|
NL292958A
(enExample)
|
1962-05-29 |
1900-01-01 |
|
|
|
GB8809205D0
(en)
|
1988-04-19 |
1988-05-25 |
Nye P C G |
Treatment of oedema
|
|
US5137871A
(en)
|
1989-07-28 |
1992-08-11 |
Regents Of The University Of California |
Treatment to reduce edema for brain and musculature injuries
|
|
DE4010536A1
(de)
*
|
1990-04-02 |
1991-10-10 |
Boehringer Mannheim Gmbh |
Pharmazeutische waessrige loesung von 4-(2-(benzolsulfonylamino)-ethyl)-phenoxyessigsaeure
|
|
US5486530A
(en)
|
1991-04-27 |
1996-01-23 |
Boehringer Mannheim Gmbh |
Use of torasemide for the treatment of brain oedemas
|
|
DE4113820A1
(de)
|
1991-04-27 |
1992-10-29 |
Boehringer Mannheim Gmbh |
Verwendung von torasemid zur behandlung von hirnoedemen
|
|
US5741671A
(en)
|
1991-12-12 |
1998-04-21 |
The Johns Hopkins University |
Isolation cloning and expression of transmembrane water channel aquaporin 1(AQP1)
|
|
US5858702A
(en)
|
1991-12-13 |
1999-01-12 |
The Johns Hopkins University |
Isolation, cloning and expression of transmembrane water channel Aquaporin 5 (AQP5)
|
|
US5519035A
(en)
|
1993-07-02 |
1996-05-21 |
Cornell Research Foundation, Inc. |
Treatment of stroke or in anticipation of the occurrence of brain ischemia
|
|
US20060167110A1
(en)
|
1995-01-13 |
2006-07-27 |
Blume Cherly D |
Methods for treating cerebrovascular disease by administering desmethylselegiline
|
|
US6391303B1
(en)
|
1996-11-18 |
2002-05-21 |
Emisphere Technologies, Inc. |
Methods and compositions for inducing oral tolerance in mammals
|
|
US6255298B1
(en)
|
1997-08-06 |
2001-07-03 |
Smithkline Beecham Corporation |
Macrophage scavenger receptor antagonists for use in the treatment of cardiovascular diseases
|
|
US5905090A
(en)
|
1998-04-29 |
1999-05-18 |
Italfarmaco S.P.A. |
Analogues of the active metabolite of leflunomide
|
|
CO5180581A1
(es)
|
1999-09-30 |
2002-07-30 |
Pfizer Prod Inc |
Compuestos para el tratamiento de la isquemia ciones farmaceuticas que los contienen para el tratamiento de la isquemia
|
|
US6500809B1
(en)
|
1999-11-12 |
2002-12-31 |
Neuron Therapeutics, Inc. |
Hyperoncotic artificial cerebrospinal fluid and method of treating neural tissue edema therewith
|
|
ATE257479T1
(de)
|
1999-12-10 |
2004-01-15 |
Pfizer |
5-ring heteroarylsubstituierte 1,4- dihydropyridine als bradykinin antagonisten
|
|
AU2002222683B9
(en)
|
2000-12-18 |
2021-12-23 |
Institute Of Medicinal Molecular Design, Inc |
Inflammatory cytokine release inhibitor
|
|
EP2438913B1
(en)
|
2002-03-20 |
2020-05-06 |
University of Maryland, Baltimore |
A non-selective cation channel in neural cells and compounds that block the channel for use in treating brain swelling
|
|
US8980952B2
(en)
|
2002-03-20 |
2015-03-17 |
University Of Maryland, Baltimore |
Methods for treating brain swelling with a compound that blocks a non-selective cation channel
|
|
CN1658854A
(zh)
|
2002-06-05 |
2005-08-24 |
株式会社医药分子设计研究所 |
免疫关联蛋白激酶抑制剂
|
|
TW200410671A
(en)
|
2002-06-05 |
2004-07-01 |
Inst Med Molecular Design Inc |
Medicines for inhibiting the activation of AP-1
|
|
EP1510207A4
(en)
|
2002-06-05 |
2008-12-31 |
Inst Med Molecular Design Inc |
THERAPEUTIC MEDICAMENT AGAINST DIABETES
|
|
CA2488363C
(en)
*
|
2002-06-06 |
2011-01-04 |
Institute Of Medicinal Molecular Design, Inc. |
O-substituted hydroxyaryl derivatives
|
|
WO2003103665A1
(ja)
|
2002-06-06 |
2003-12-18 |
株式会社医薬分子設計研究所 |
抗アレルギー薬
|
|
US20060014811A1
(en)
|
2002-06-10 |
2006-01-19 |
Susumu Muto |
Medicament for treatment of cancer
|
|
EP1535609A4
(en)
|
2002-06-10 |
2009-01-07 |
Inst Med Molecular Design Inc |
Nf-kb activation inhibitors
|
|
US20060035944A1
(en)
|
2002-06-11 |
2006-02-16 |
Susumu Muto |
Remedies for neurodegenerative diseases
|
|
EP1542699A4
(en)
|
2002-07-15 |
2009-03-25 |
Myriad Genetics Inc |
COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
|
|
ES2398460T3
(es)
|
2003-02-06 |
2013-03-19 |
Queen's University Of Belfast |
Péptido antagonista del receptor B2 de bradiquinina proveniente de la piel de un anfibio
|
|
EA013846B1
(ru)
|
2003-05-01 |
2010-08-30 |
Инноджен Калбиотех Пте Лтд. |
Фармацевтическая композиция, содержащая лактат, и ее применение
|
|
US20070042997A1
(en)
|
2003-07-16 |
2007-02-22 |
Akiko Itai |
Medicament for treatment of dermal pigmentation
|
|
JP2007509044A
(ja)
|
2003-10-08 |
2007-04-12 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
シクロアルキルピラニル基を含むａｔｐ結合カセットトランスポーターのモジュレータ
|
|
US8467876B2
(en)
|
2003-10-15 |
2013-06-18 |
Rmx, Llc |
Breathing disorder detection and therapy delivery device and method
|
|
JPWO2005039556A1
(ja)
|
2003-10-29 |
2007-02-15 |
紘一 首藤 |
血行再建術後の再狭窄又は再閉塞の治療及び／又は予防のための医薬
|
|
EP1691817A2
(en)
|
2003-12-02 |
2006-08-23 |
Corgentech, Inc. |
NF-kB OLIGONUCLEOTIDE DECOY MOLECULES
|
|
CN101043891A
(zh)
|
2004-09-18 |
2007-09-26 |
巴尔的摩马里兰大学 |
靶向NCCa－ATP通道的治疗剂及其使用方法
|
|
AU2005287090A1
(en)
|
2004-09-18 |
2006-03-30 |
Department Of Veterans Affairs |
Therapeutic agents targeting the NCca-ATP channel and methods of use thereof
|
|
US7601745B2
(en)
|
2004-09-27 |
2009-10-13 |
4Sc Ag |
Heterocyclic NF-kB inhibitors
|
|
MX2007008159A
(es)
|
2005-01-04 |
2007-10-11 |
Novartis Ag |
Biomarcadores para identificar la eficacia del tegaserod en pacientes con constipacion cronica.
|
|
MY147790A
(en)
|
2005-04-28 |
2013-01-31 |
Takeda Pharmaceutical |
Stable emulsion composition
|
|
WO2007084464A2
(en)
|
2006-01-17 |
2007-07-26 |
The University Of North Carolina At Chapel Hill |
Water channel blockers and methods of use thereof
|
|
JP4273235B2
(ja)
|
2006-06-01 |
2009-06-03 |
国立大学法人 新潟大学 |
アクアポリン４阻害薬
|
|
WO2008060705A2
(en)
|
2006-06-06 |
2008-05-22 |
Genentech, Inc. |
Anti-dll4 antibodies and methods using same
|
|
RU2008152435A
(ru)
|
2006-06-06 |
2010-07-20 |
Дженентек, Инк. (Us) |
Композиции и способы регулирования развития сосудов
|
|
US7671058B2
(en)
|
2006-06-21 |
2010-03-02 |
Institute Of Medicinal Molecular Design, Inc. |
N-(3,4-disubstituted phenyl) salicylamide derivatives
|
|
US10004703B2
(en)
|
2006-10-12 |
2018-06-26 |
Biogen Chesapeake Llc |
Treatment of alzheimer's disease using compounds that reduce the activity of non-selective CA++ activated ATP-sensitive cation channels regulated by SUR1 channels
|
|
WO2008046014A1
(en)
|
2006-10-12 |
2008-04-17 |
Remedy Pharmaceuticals, Inc. |
Treatment of alzheimer's disease using compounds that reduce the activity of non-selective ca++- activated atp-sensitive cation channels regulated by sur1 receptors
|
|
CA2669117A1
(en)
|
2006-10-26 |
2008-05-02 |
Gary A. Flynn |
Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance
|
|
US9316633B2
(en)
|
2006-11-16 |
2016-04-19 |
The Regents Of The University Of California |
Methods for identifying inhibitors of solute transporters
|
|
WO2008067373A2
(en)
|
2006-11-28 |
2008-06-05 |
Alcon Research, Ltd. |
RNAi-MEDIATED INHIBITION OF AQUAPORIN 1 FOR TREATMENT OF IOP-RELATED CONDITIONS
|
|
WO2008067382A2
(en)
|
2006-11-28 |
2008-06-05 |
Alcon Research, Ltd. |
Rnai-mediated inhibition of aquaporin 4 for treatment of iop-related conditions
|
|
WO2008089103A2
(en)
|
2007-01-12 |
2008-07-24 |
University Of Maryland, Baltimore |
Targeting ncca-atp channel for organ protection following ischemic episode
|
|
TWI629058B
(zh)
|
2007-01-16 |
2018-07-11 |
陳建宏 |
醫藥組成物及其用途
|
|
US20120183600A1
(en)
|
2007-01-16 |
2012-07-19 |
Chien-Hung Chen |
Novel composition for treating metabolic syndrome and other conditions
|
|
CA2618099C
(en)
|
2007-02-09 |
2016-09-20 |
University Of Maryland, Baltimore |
Antagonists of a non-selective cation channel in neural cells
|
|
CA2678486C
(en)
|
2007-02-17 |
2019-03-12 |
President And Fellows Of Harvard College |
Compositions and method for tissue preservation
|
|
WO2008133884A2
(en)
|
2007-04-23 |
2008-11-06 |
Combinatorx, Incorporated |
Methods and compositions for the treatment of neurodegenerative disorders
|
|
CA3065983C
(en)
|
2007-06-22 |
2022-07-26 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Inhibitors of ncca-atp channels for therapy
|
|
WO2009006555A2
(en)
|
2007-07-02 |
2009-01-08 |
Yu, Ming |
Methods, composition, targets for combinational cancer treatments
|
|
CN102872020A
(zh)
*
|
2007-10-23 |
2013-01-16 |
株式会社医药分子设计研究所 |
Pai-1产生抑制剂
|
|
US20090239868A1
(en)
|
2007-10-23 |
2009-09-24 |
Institute Of Medical Molecular Design, Inc. |
Inhibitor of pai-1 production
|
|
EP2868315B1
(en)
|
2007-12-04 |
2017-05-31 |
Remedy Pharmaceuticals, Inc. |
Improved formulations and methods for lyophilization and lyophilates provided thereby
|
|
GB0724340D0
(en)
|
2007-12-13 |
2008-01-30 |
Univ Dundee |
Novel Therapeutic Agents
|
|
WO2009086303A2
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
US20110034560A1
(en)
|
2008-01-29 |
2011-02-10 |
Sven Jacobson |
Liquid formulations of compounds active at sulfonylurea receptors
|
|
US8211882B2
(en)
*
|
2008-03-08 |
2012-07-03 |
Richard Delarey Wood |
Glutamate receptor modulators and therapeutic agents
|
|
WO2009139925A1
(en)
|
2008-05-16 |
2009-11-19 |
Panacea Pharmaceuticals, Inc. |
Methods for the treatment of brain edema
|
|
EP2719380A3
(en)
|
2008-09-16 |
2014-07-30 |
University of Maryland, Baltimore |
SUR1 inhibitors for therapy
|
|
US20120010178A1
(en)
|
2008-10-21 |
2012-01-12 |
President And Fellows Of Harvard College |
Methods and compounds for treatment of neurodegenerative disorders
|
|
GB0823366D0
(en)
|
2008-12-22 |
2009-01-28 |
Uni I Oslo |
Synthesis
|
|
CN102348668B
(zh)
|
2009-01-12 |
2014-11-19 |
培力有限公司 |
化合物及其用于治疗炎症和调节免疫应答的用途
|
|
WO2010096627A1
(en)
|
2009-02-20 |
2010-08-26 |
Lisanti Michael P |
Therapeutics and methods for treating neoplastic diseases comprising determining the level of caveolin-1 and/or caveolin-2 in a stromal cell sample
|
|
RU2564900C2
(ru)
|
2010-03-10 |
2015-10-10 |
Дзе Юниверсити Оф Флорида Рисерч Фаундейшн, Инк. |
Модулирование аквапоринов релаксином
|
|
KR20230165363A
(ko)
|
2010-07-19 |
2023-12-05 |
바이오젠 체사피크 엘엘씨 |
글리부리드 및 다른 약물의 정맥내 투여를 위한 방법
|
|
EP2598145A1
(en)
*
|
2010-07-28 |
2013-06-05 |
Boehringer Ingelheim International GmbH |
Pharmaceutical composition for treatment of respiratory and inflammatory diseases
|
|
US20110052678A1
(en)
|
2010-11-05 |
2011-03-03 |
Shantha Totada R |
Method for treating age related macular degeneration
|
|
US20120238623A1
(en)
|
2011-03-14 |
2012-09-20 |
Chandraratna Roshantha A |
Inflammation and Autoimmune Disorder Treatment using RARa Selective Agonists
|
|
US9290765B2
(en)
|
2011-05-02 |
2016-03-22 |
Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patiëntenzorg |
Protection against endothelial barrier dysfunction through inhibition of the tyrosine kinase abl-related gene (ARG)
|
|
RU2461375C1
(ru)
*
|
2011-05-19 |
2012-09-20 |
Учреждение Российской академии медицинских наук Научно-исследовательский институт онкологии Сибирского отделения Российской академии медицинских наук (НИИ онкологии СО РАМН) |
Способ комбинированного лечения больных местно-распространенным раком желудка
|
|
WO2013152313A1
(en)
*
|
2012-04-05 |
2013-10-10 |
The Regents Of The University Of California |
Compositions and methods for treating cancer and diseases and conditions responsive to growth factor inhibition
|
|
US9452973B2
(en)
|
2012-05-04 |
2016-09-27 |
The United States Of America, As Represented By The Secretary Department Of Health And Human Services |
Modulators of the relaxin receptor 1
|
|
BR112014027983B1
(pt)
|
2012-05-08 |
2022-05-24 |
Aeromics, Inc |
Uso de inibidores de aquaporina seletivos
|
|
CN105636583B
(zh)
|
2013-09-13 |
2019-08-20 |
板井昭子 |
水溶液制剂及其制造方法
|
|
RU2691951C2
(ru)
|
2013-11-06 |
2019-06-19 |
Аэромикс, Инк. |
Новые составы
|
|
US9163042B2
(en)
|
2013-12-13 |
2015-10-20 |
Vertex Pharmaceuticals Incorporated |
Prodrugs of pyridone amides useful as modulators of sodium channels
|
|
CN107207417A
(zh)
|
2014-11-13 |
2017-09-26 |
埃罗米克斯公司 |
新方法
|
|
MA45307A
(fr)
|
2015-05-29 |
2018-04-11 |
Biogen Chesapeake Llc |
Procédés de réduction ou de prévention des dommages à l'intima provoqués par une stimulation mécanique de cellules endothéliales
|
|
CN108348534A
(zh)
|
2015-10-07 |
2018-07-31 |
生物切萨皮克有限责任公司 |
治疗与cns水肿相关的损伤或状况的方法
|
|
AU2017261828B2
(en)
|
2016-05-13 |
2023-04-13 |
Aeromics, Inc. |
Crystals
|
|
EP4483955A3
(en)
|
2016-07-29 |
2025-03-12 |
Remedy Pharmaceuticals, Inc. |
Methods of medical treatment with sur1-trpm4 channel inhibitors
|
|
MX2023001493A
(es)
|
2020-08-05 |
2023-06-23 |
Jiangsu Simcere Pharm Co Ltd |
Composicion farmaceutica de un inhibidor de la acuaporina y metodo para la preparacion de la misma.
|